115 related articles for article (PubMed ID: 8123656)
1. Response of plasma tissue factor pathway inhibitor to diet-induced hypercholesterolemia in crab-eating monkeys.
Abumiya T; Nakamura S; Takenaka A; Takenaka O; Yoshikuni Y; Miyamoto S; Kimura T; Enjyoji K; Kato H
Arterioscler Thromb; 1994 Mar; 14(3):483-8. PubMed ID: 8123656
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a).
Lesnik P; Vonica A; Guérin M; Moreau M; Chapman MJ
Arterioscler Thromb; 1993 Jul; 13(7):1066-75. PubMed ID: 8318508
[TBL] [Abstract][Full Text] [Related]
3. Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.
Hansen JB; Huseby NE; Sandset PM; Svensson B; Lyngmo V; Nordøy A
Arterioscler Thromb; 1994 Feb; 14(2):223-9. PubMed ID: 8305412
[TBL] [Abstract][Full Text] [Related]
4. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Zitoun D; Bara L; Basdevant A; Samama MM
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia.
Kokawa T; Abumiya T; Kimura T; Harada-Shiba M; Koh H; Tsushima M; Yamamoto A; Kato H
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):504-10. PubMed ID: 7749862
[TBL] [Abstract][Full Text] [Related]
6. Response of rhesus serum high density lipoproteins to cycles of diet-induced hypercholesterolemia.
Fless GM; Juhn D; Karlin J; Rubenstein A; Scanu AM
Arteriosclerosis; 1984; 4(2):154-64. PubMed ID: 6422917
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients.
Morishita E; Asakura H; Saito M; Yamazaki M; Ontachi Y; Mizutani T; Kato M; Matsuda T; Nakao S
Atherosclerosis; 2001 Jan; 154(1):203-12. PubMed ID: 11137101
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor; its structure, function and clinical significance.
Kato H
Pol J Pharmacol; 1996; 48(1):67-72. PubMed ID: 9112630
[TBL] [Abstract][Full Text] [Related]
9. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II.
Kawaguchi A; Miyao Y; Noguchi T; Nonogi H; Yamagishi M; Miyatake K; Kamikubo Y; Kumeda K; Tsushima M; Yamamoto A; Kato H
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):251-8. PubMed ID: 10634826
[TBL] [Abstract][Full Text] [Related]
10. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
Moor E; Hamsten A; Karpe F; Båvenholm P; Blombäck M; Silveira A
Thromb Haemost; 1994 Jun; 71(6):707-12. PubMed ID: 7974336
[TBL] [Abstract][Full Text] [Related]
11. Heparin/low molecular weight heparin and tissue factor pathway inhibitor.
Abildgaard U
Haemostasis; 1993 Mar; 23 Suppl 1():103-6. PubMed ID: 8388347
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma lipoprotein concentrations and compositions upon feeding cholesterol in high- and low-responding rhesus monkeys.
Myers LH; Bhattacharyya AK; Eggen DA; Strong JP
Ann Nutr Metab; 1990; 34(6):317-26. PubMed ID: 2076023
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term protein deficiency on plasma lipoprotein concentrations and metabolism in rhesus monkeys.
Portman OW; Alexander M; Neuringer M; Illingworth DR; Alam SS
J Nutr; 1981 Apr; 111(4):733-45. PubMed ID: 7218044
[TBL] [Abstract][Full Text] [Related]
14. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects.
Schaefer EJ; Levy RI; Ernst ND; Van Sant FD; Brewer HB
Am J Clin Nutr; 1981 Sep; 34(9):1758-63. PubMed ID: 6945041
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.
Valentin S; Nordfang O; Bregengård C; Wildgoose P
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):713-20. PubMed ID: 8292720
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of very low density lipoproteins in diet induced hypercholesterolemic pigtail monkeys (Macaca nemestrina).
Kushwaha RS; Hazzard WR
Biochim Biophys Acta; 1980 Jul; 619(1):142-55. PubMed ID: 7417463
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors influence the atherogenic response of lipoproteins to dietary fat and cholesterol in nonhuman primates.
Rudel LL
J Am Coll Nutr; 1997 Aug; 16(4):306-12. PubMed ID: 9263179
[TBL] [Abstract][Full Text] [Related]
18. Development of a method to separate lipoprotein-bound and lipoprotein-depleted tissue factor pathway inhibitor. Measurement of free tissue factor pathway inhibitor activity.
Bridey F; Lacombe C; Sustendal L; Moatti D; Combe F; Mammès O; de Prost D
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):637-43. PubMed ID: 9863713
[TBL] [Abstract][Full Text] [Related]
19. Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia.
Hansen JB; Huseby KR; Huseby NE; Sandset PM; Hanssen TA; Nordøy A
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):879-85. PubMed ID: 7600119
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dietary-induced hypercholesterolemia in the chicken.
Hermier D; Dillon JC
Biochim Biophys Acta; 1992 Mar; 1124(2):178-84. PubMed ID: 1543739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
